Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on June 25, 2026

Jun. 25, 2026

Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)

Indeterminate GlobeNewswire

Jun. 25, 2026

Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial

Indeterminate GlobeNewswire

Jun. 25, 2026

Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Indeterminate GlobeNewswire

Jun. 25, 2026

TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth

Indeterminate GlobeNewswire

Jun. 25, 2026

Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Jun. 25, 2026

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Indeterminate GlobeNewswire

Jun. 25, 2026

Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel

Indeterminate GlobeNewswire

Jun. 25, 2026

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire

Jun. 25, 2026

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Indeterminate GlobeNewswire

Jun. 25, 2026

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

Indeterminate GlobeNewswire

Jun. 25, 2026

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Indeterminate GlobeNewswire

Jun. 25, 2026

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

Satellos to Present Clinical Program Updates at ICNMD 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

Verano to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

Indeterminate GlobeNewswire

Jun. 25, 2026

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Indeterminate GlobeNewswire

Jun. 25, 2026

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Indeterminate GlobeNewswire

Jun. 25, 2026

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

Indeterminate GlobeNewswire

Jun. 25, 2026

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

Indeterminate GlobeNewswire

Jun. 25, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Indeterminate GlobeNewswire